CARA WEIDINGER: Open Payments
NPI 1720826092 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,381 in 60 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $738 · 2025 $1,381
Food & beverage: $1,301Education: $80
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $302 |
| GlaxoSmithKline, LLC. | 12 | $218 |
| Regeneron Healthcare Solutions, Inc. | 6 | $176 |
| GENZYME CORPORATION | 8 | $169 |
| ANI Pharmaceuticals, Inc. | 3 | $100 |
| Merck Sharp & Dohme LLC | 3 | $76 |
| Amgen Inc. | 3 | $52 |
| United Therapeutics Corporation | 2 | $45 |
| Mallinckrodt Hospital Products Inc. | 2 | $43 |
| PFIZER INC. | 2 | $42 |
Products named: DUPIXENT, TRELEGY ELLIPTA, BREZTRI, PURIFIED CORTROPHIN GEL, FASENRA, TEZSPIRE, WINREVAIR, Tyvaso.
Industry payments across VA — which companies pay providers there.
